Related Experiment Videos
Identification of a novel Bcl-2 related gene, BRAG-1, in human glioma
R Das1, E P Reddy, D Chatterjee
1Department of Neurosurgery, Thomas Jefferson University Hospital-Wills Neurosensory Institute, Philadelphia, Pennsylvania 19107, USA.
Abstract:
Programmed cell death (apoptosis) plays a major role in embryogenesis, in mature organ homeostasis and in many disease states including cancer. Apoptosis occurs as an orderly cell-intrinsic suicide program regulated by a family of genes related to Bcl-2. Here, we describe the cloning and molecular characterization of a gene homologous to Bcl-2 from a human glioma. This gene named BRAG-1 (for brain-related apoptosis gene) has an open reading frame that encodes for a protein of 31 kDa sharing significant sequence homology with the Bcl-2 family of genes in the BH1 and BH2 regions. Northern blot analyses revealed that BRAG-1 is expressed in human gliomas as a 1.8 kb message. This gene, interestingly, was found to be expressed predominantly in normal human brain as a 4.5 kb transcript which is different in size from the message found in tumor tissues. These results suggest that BRAG-1 may be rearranged in human gliomas leading to its over-expression as a truncated transcript. Utilizing a bacterial expression vector, we produced BRAG-1 protein which was found to cross-react with a Bcl-2 monoclonal antibody, further suggesting structural and immunological similarity to Bcl-2.
Insights
Researchers identified a new gene, BRAG-1, involved in programmed cell death (apoptosis) and brain tumors. This gene shows similarities to Bcl-2 and may be altered in gliomas, potentially affecting apoptosis regulation.
Area of Science:
- Molecular Biology
- Cancer Research
- Neuro-oncology
Background:
- Programmed cell death (apoptosis) is crucial for development, homeostasis, and diseases like cancer.
- The Bcl-2 gene family regulates apoptosis through intrinsic cell pathways.
- Understanding apoptosis regulators is key to cancer therapy.
Purpose of the Study:
- To clone and characterize a novel gene homologous to Bcl-2 from human glioma.
- To investigate the role of this gene in glioma development and apoptosis.
- To explore potential therapeutic targets related to apoptosis in brain tumors.
Main Methods:
- Cloning and molecular characterization of the novel gene, named BRAG-1.
- Sequence homology analysis with the Bcl-2 family.
- Northern blot analysis to study gene expression in normal brain and gliomas.
- Bacterial expression and antibody cross-reactivity assays.
Main Results:
- Identified and cloned BRAG-1, encoding a 31 kDa protein with homology to Bcl-2 in BH1 and BH2 regions.
- BRAG-1 expressed as a 1.8 kb transcript in human gliomas.
- Normal human brain predominantly expressed a different-sized transcript (4.5 kb).
- BRAG-1 protein showed cross-reactivity with a Bcl-2 monoclonal antibody.
Conclusions:
- BRAG-1 is a novel brain-related apoptosis gene homologous to Bcl-2.
- BRAG-1 may be rearranged in human gliomas, leading to altered expression of a truncated transcript.
- These findings suggest BRAG-1's potential role in glioma pathogenesis and as a target for apoptosis-based therapies.